Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 657.80

+1.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotechwantabe who wrote (3222)	1/26/2021 10:31:01 PM
From: Felix B	Read Replies (2) of 3557

Wouldn't SC only be approved for the prophylactic setting? If so, I am still not sure how big of an uptick there will be. They and Lily paint a rosy picture I am just not optimistic and think some people will prefer to just wait for a vaccine. Sure for those very specific use cases maybe, at the end of they if it saves lives or prevents infections it's a win. I don't see as much of a increase in usage but would love to be wrong. Those numbers you linked are for allocation correct? Is there for actual patient treated? UK data or hospitalized data could be impactful?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next